NCT00486369View on ClinicalTrials.gov

SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2007

Conditions
Osteoarthritis
Interventions
DRUG

Oral salmon calcitonin

Trial Locations (1)

2750

CCBR A/S, Ballerup Municipality

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Nordic Bioscience A/S

INDUSTRY